Gene · 2043
Papers2,263
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,263
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neurodegeneration-associated protein VAPB regulates proliferation in medulloblastoma. | Sci Rep | 2023 | 37945695 | PubTator, text mining | PubMed |
| Regulation of axon pathfinding by astroglia across genetic model organisms. | Front Cell Neurosci | 2023 | 37941606 | PubTator, text mining | PubMed |
| Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury. | J Neuroinflammation | 2023 | 37941008 | PubTator, text mining | PubMed |
| Construct validity of a questionnaire for measuring student engagement in problem-based learning tutorials. | BMC Med Educ | 2023 | 37936152 | PubTator, text mining | PubMed |
| Applications of advanced technologies for detecting genomic structural variation. | Mutat Res Rev Mutat Res | 2023 | 37931775 | PubTator, text mining | PubMed |
| Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma. | Oncol Lett | 2023 | 37927410 | PubTator, text mining | PubMed |
| Effect of Aging on Tendon Biology, Biomechanics and Implications for Treatment Approaches. | Int J Mol Sci | 2023 | 37894875 | PubTator, text mining | PubMed |
| Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis. | BMJ | 2023 | 37890889 | PubTator, text mining | PubMed |
| EphrinA5 regulates cell motility by modulating Snhg15/DNA triplex-dependent targeting of DNMT1 to the Ncam1 promoter. | Epigenetics Chromatin | 2023 | 37880732 | PubTator, text mining | PubMed |
| Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits). | BMC Psychiatry | 2023 | 37872497 | PubTator, text mining | PubMed |
| Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer. | Mol Cancer | 2023 | 37853437 | PubTator, text mining | PubMed |
| Investigation into the prevalence of enterotoxin genes and genetic background of Staphylococcus aureus isolates from retain foods in Hangzhou, China. | BMC Microbiol | 2023 | 37848808 | PubTator, text mining | PubMed |
| Corrigendum to "Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer" [Biochem. Biophys. Res. Commun. 680 (2023) 161-170]. | Biochem Biophys Res Commun | 2023 | 37839952 | PubTator, text mining | PubMed |
In Cerebellar Atrophy of 12-Month-Old ATM-Null Mice, Transcriptome Upregulations Concern Most Neurotransmission and Neuropeptide Pathways, While Downregulations Affect Prominently Itpr1, Usp2 and Non-Coding RNA. | Cells | 2023 | 37830614 | PubTator, text mining | PubMed |
| Comparative transcriptomics reveals human-specific cortical features. | Science | 2023 | 37824638 | PubTator, text mining | PubMed |
| Downregulation of EphA2 stability by RNF5 limits its tumor-suppressive function in HER2-negative breast cancers. | Cell Death Dis | 2023 | 37816703 | PubTator, text mining | PubMed |
| In-silico and structure-based assessment to evaluate pathogenicity of missense mutations associated with non-small cell lung cancer identified in the Eph-ephrin class of proteins. | Genomics Inform | 2023 | 37813626 | PubTator, text mining | PubMed |
| Endothelial deletion of EPH receptor A4 alters single-cell profile and Tie2/Akap12 signaling to preserve blood-brain barrier integrity. | Proc Natl Acad Sci U S A | 2023 | 37796990 | PubTator, text mining | PubMed |
| Transcriptome-based analysis of human peripheral blood reveals regulators of immune response in different viral infections. | Front Immunol | 2023 | 37795081 | PubTator, text mining | PubMed |
| ESX1 gene as a potential candidate responsible for male infertility in nonobstructive azoospermia. | Sci Rep | 2023 | 37783880 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2043/papers?page=7